It appears JavaScript is disabled. In order for this website to function correctly you need to enable JavaScript in your browser.

Back to safety notices

PRAC meeting highlights 05 - 08 May 2025

09/05/2025

Medicines for human use Pharmacovigilance risk assessment committee (PRAC)

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the May 2025 meeting are now available on the EMA website